Impulse control disorders in parkinson disease: A multicenter case-control study

Annals of Neurology

Volumn 69, Issue 6, 2011, Pages 986-996

  Voon, Valerie ^a   Sohr, Mandy ^b   Lang, Anthony E ^c   Potenza, Marc N ^d   Siderowf, Andrew D ^e   Whetteckey, Jacqueline ^f   Weintraub, Daniel ^e   Wunderlich, Glen R ^g   Stacy, Mark ^h  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c UNIVERSITY OF TORONTO   (Canada)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^g BOEHRINGER INGELHEIM CANADA LTD   (Canada)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; CASE CONTROL STUDY; COGNITIVE DEFECT; COMPULSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSKINESIA; EMOTIONAL DISORDER; FEEDING BEHAVIOR; FEMALE; FUNCTIONAL DISEASE; HUMAN; IMPULSE CONTROL DISORDER; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTICENTER STUDY; NEUROLOGIC EXAMINATION; OBSESSION; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PRIORITY JOURNAL; SEXUAL BEHAVIOR;

AGED; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; CASE-CONTROL STUDIES; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; DOPAMINE AGONISTS; FEMALE; HUMANS; IMPULSE CONTROL DISORDERS; LEVODOPA; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES;

EID: 79957658379     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22356     Document Type: Article

References (37)

1. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010; 67: 589-595.
2. Barns Neurauter MP, Rickards H, Cavanna AE., The prevalence and clinical characteristics of pathological gambling in Parkinson's disease: an evidence-based review. Funct Neurol 2010; 25: 9-13.
3. Silveira-Moriyama L, Evans AH, Katzenschlager R, et al. Punding and dyskinesias. Mov Disord 2006; 21: 2214-2217. (Pubitemid 46140441)
4. Pontone G, Williams JR, Bassett SS, et al. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 2006; 67: 1258-1261. (Pubitemid 44563839)
5. Voon V, Thomsen T, Miyasaki JM, et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 2007; 64: 212-216.
6. Housden CR, O'Sullivan SS, Joyce EM, et al. Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviors. Neuropsychopharmacology 2010; 35: 2155-2164.
7. Voon V, Reynolds B, Brezing C, et al. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) 2010; 207: 645-659.
8. Shaffer HJ, LaBrie R, Scanlan KM, et al. Pathological gambling among adolescents: Massachusetts Gambling Screen (MAGS). J Gambl Stud 1994; 10: 339-362.
9. Christenson GA, Faber RJ, de Zwaan M, et al. Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry 1994; 55: 5-11. (Pubitemid 24051910)
10. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.
11. Goetz CG, Stebbins GT, Chmura TA, et al. Teaching tape for the motor section of the unified Parkinson's disease rating scale. Mov Disord 1995; 10: 263-266.
12. Nazem S, Siderowf AD, Duda JE, et al. Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score. J Am Geriatr Soc 2009; 57: 304-308.
13. Weintraub D, Xie S, Karlawish J, et al. Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: evidence from the 15-item Geriatric Depression Scale (GDS-15). Int J Geriatr Psychiatry 2007; 22: 1025-1030. (Pubitemid 47616779)
14. Foa EB, Huppert JD, Leiberg S, et al. The Obsessive-Compulsive Inventory: development and validation of a short version. Psychol Assess 2002; 14: 485-496. (Pubitemid 35440493)
15. Leentjens AF, Dujardin K, Marsh L, et al. Anxiety rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2008; 23: 2015-2025.
16. Cloninger CR, Svrakic DM, Przybeck TR., A psychobiological model of temperament and character. Arch Gen Psychiatry 1993; 50: 975-990. (Pubitemid 23361478)
17. Patton JH, Stanford MS, Barratt ES., Factor structure of the Barratt impulsiveness scale. J Clin Psychol 1995; 51: 768-774. (Pubitemid 26021724)
18. Kirby KN, Petry NM, Bickel WK., Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen 1999; 128: 78-87.
19. Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction 1993; 88: 791-804. (Pubitemid 23194530)
20. Kang GA, Bronstein JM, Masterman DL, et al. Clinical characteristics in early Parkinson's disease in a central California population-based study. Mov Disord 2005; 20: 1133-1142. (Pubitemid 41632200)
21. Menza M, Marin H, Kaufman K, et al. Citalopram treatment of depression in Parkinson's disease: the impact on anxiety, disability, and cognition. J Neuropsychiatry Clin Neurosci 2004; 16: 315-319. (Pubitemid 39244557)
22. Potenza MN, Xian H, Shah K, et al. Shared genetic contributions to pathological gambling and major depression in men. Arch Gen Psychiatry 2005; 62: 1015-1021. (Pubitemid 41248381)
23. Romer Thomsen K, Callesen MB, Linnet J, et al. Severity of gambling is associated with severity of depressive symptoms in pathological gamblers. Behav Pharmacol 2009; 20: 527-536.
24. Grant JE, Potenza MN., Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. Int Clin Psychopharmacol 2006; 21: 203-209. (Pubitemid 43740297)
25. Blanco C, Potenza MN, Kim SW, et al. A pilot study of impulsivity and compulsivity in pathological gambling. Psychiatry Res 2009; 167: 161-168.
26. Menza M., The personality associated with Parkinson's disease. Curr Psychiatry Rep 2000; 2: 421-426.
27. Allam MF, Campbell MJ, Del Castillo AS, et al. Parkinson's disease protects against smoking? Behav Neurol 2004; 15: 65-71. (Pubitemid 40202500)
28. Evans AH, Lawrence AD, Potts J, et al. Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 317-321.
29. Lejoyeux M, Weinstein A., Compulsive buying. Am J Drug Alcohol Abuse 2010; 36: 248-253.
30. Hudson JI, Hiripi E, Pope HG Jr, et al. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007; 61: 348-358. (Pubitemid 46108682)
31. Blanco C, Hasin DS, Petry N, et al. Sex differences in subclinical and DSM-IV pathological gambling: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 2006; 36: 943-953. (Pubitemid 43827366)
32. Eagle DM, Baunez C., Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci Biobehav Rev 2010; 34: 50-72.
33. Thaler RH., Some empirical evidence of dynamic inconsistency. Econ Lett 1981; 81: 201-207.
34. Kahnemann D, Tversky A., Prospect theory: an analysis of decision under risk. In:, Kahnemann D, Tversky A, eds. Choices, values and frames. New York, NY: Cambridge University Press, 2000: 26.
35. Pine A, Seymour B, Roiser JP, et al. Encoding of marginal utility across time in the human brain. J Neurosci 2009; 29: 9575-9581.
36. Rodriguez-Oroz MC, Lopez-Azcarate J, Garcia-Garcia D, et al. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. Brain 2011; 134 (pt 1): 36-49.
37. Voon V, Fernagut PO, Wickens J, et al. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol 2009; 8: 1140-1149.